Fig. 1From: Midostaurin preferentially attenuates proliferation of triple-negative breast cancer cell lines through inhibition of Aurora kinase familyGrowth inhibition of breast cancer cell lines by midostaurin. The 19 breast cancer cell lines were treated with 1 μM midostaurin for 72 h, and cell viability was measured. a Cell viability shown as a ratio relative to the control sample without treatment. Bars are 1 s.d. of quintuple experiments. Breast cancer subtypes are indicated as follows: gray, TNBC; light gray, HER2; white, ER+. b Box plot showing relative viability according to breast cancer subtypes. TNBC vs. non-TNBC, p = 0.00075 by Welch’s t-testBack to article page